Epstein-Barr virus: latency and infections in the immunocompromised hostRICKINSON, A. B.Fondation franco-allemande. Journées immunologiques. 1989, pp 184-191Conference Paper

In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patientsSTRANG, G; RICKINSON, A. B.Immunology (Oxford). 1987, Vol 62, Num 4, pp 647-654, issn 0019-2805Article

Multiple HLA class I-dependent cytotoxicities constitute the non-HLA-restricted response in infectious mononucleosisSTRANG, G; RICKINSON, A. B.European journal of immunology. 1987, Vol 17, Num 7, pp 1007-1013, issn 0014-2980Article

Different epstein-barr virus-B cell interactions in phenotypically distinct clones of a burkitt's lymphoma cell lineGREGORY, C. D; ROWE, M; RICKINSON, A. B et al.Journal of general virology. 1990, Vol 71, Num 7, pp 1481-1495, issn 0022-1317, 15 p.Article

Immune intervention against virus-associated human cancersRICKINSON, A. B.Annals of oncology. 1995, Vol 6, pp S69-S71, issn 0923-7534, SUP1Conference Paper

Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cellsRICKINSON, A. B; YOUNG, L. S; ROWE, M et al.Journal of virology. 1987, Vol 61, Num 5, pp 1310-1317, issn 0022-538XArticle

Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densitiesYAO, Q. Y; CZARNECKA, H; RICKINSON, A. B et al.International journal of cancer. 1991, Vol 48, Num 2, pp 253-257, issn 0020-7136, 5 p.Article

Burkitt's lymphomaRICKINSON, A. B; GREGORY, C. D.Transactions of the Royal Society of Tropical Medicine and Hygiene. 1988, Vol 82, Num 5, pp 657-659, issn 0035-9203Article

The Epstein-Barr virus as a model of virus-host interactionsRICKINSON, A. B; YAO, Q. Y; WALLACE, L. E et al.British medical bulletin. 1985, Vol 41, Num 1, pp 75-79, issn 0007-1420Article

Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiationDAWSON, C. W; RICKINSON, A. B; YOUNG, L. S et al.Nature (London). 1990, Vol 344, Num 6268, pp 777-780, issn 0028-0836, 4 p.Article

Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigenGASTON, J. S. H; RICKINSON, A. B; EPSTEIN, M. A et al.The Journal of experimental medicine. 1983, Vol 158, Num 2, pp 280-293, issn 0022-1007Article

Oropharyngeal shedding of infectious Epstein-Barr virus in healthy virus-immune donorsYAO QING-YUN; RICKINSON, A. B; EPSTEIN, M. A et al.Chinese medical journal. 1985, Vol 98, Num 3, pp 191-196, issn 0366-6999Article

A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individualsYAO, Q. Y; RICKINSON, A. B; EPSTEIN, M. A et al.International journal of cancer. 1985, Vol 35, Num 1, pp 35-42, issn 0020-7136Article

Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinantsGASTON, J. S. H; RICKINSON, A. B; EPSTEIN, M. A et al.The Journal of experimental medicine. 1983, Vol 158, Num 6, pp 1804-1821, issn 0022-1007Article

Dual stimulation of Epstein-Barr virus (EBV)-specific CD4⁺- and CD8⁺-T-cell responses by a chimeric antigen construct: Potential therapeutic vaccine for EBV-positive nasopharyngeal carcinomaTAYLOR, G. S; HAIGH, T. A; GUDGEON, T. N. H et al.Journal of virology. 2004, Vol 78, Num 2, pp 768-778, issn 0022-538X, 11 p.Article

Analyis of V_H genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneityCHAPMAN, C. J; MOCKRIDGE, C. I; ROWE, M et al.Blood. 1995, Vol 85, Num 8, pp 2176-2181, issn 0006-4971Article

Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1 : a B-cell-specific response that is delayed relative to NF-κB activation and to induction of cell surface markersROWE, M; PENG-PILON, M; HUEN, D. S et al.Journal of virology. 1994, Vol 68, Num 9, pp 5602-5612, issn 0022-538XArticle

Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinomaSAM, C. K; BROOKS, L. A; NIEDOBITEK, G et al.International journal of cancer. 1993, Vol 53, Num 6, pp 957-962, issn 0020-7136Article

MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathwaysLEE, S. P; WALLACE, L. E; MACKETT, M et al.International immunology. 1993, Vol 5, Num 5, pp 451-460, issn 0953-8178Article

Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4GAVIOLI, R; KURILLA, M. G; DE CAMPOS-LIMA, P. O et al.Journal of virology. 1993, Vol 67, Num 3, pp 1572-1578, issn 0022-538XArticle

Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model : implications for the pathogenesis of EBV-positive lymphomas in manROWE, M; YOUNG, L. S; CROCKER, J et al.The Journal of experimental medicine. 1991, Vol 173, Num 1, pp 147-158, issn 0022-1007, 12 p.Article

Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cellsMURRAY, R. J; BROOKS, J. M; RICKINSON, A. B et al.European journal of immunology. 1990, Vol 20, Num 3, pp 659-664, issn 0014-2980Article

Epstein-Barr virus gene expression in malignant lymphomas induced by experimental virus infection of cottontop tamarinsYOUNG, L. S; FINERTY, S; BROOKS, L et al.Journal of virology. 1989, Vol 63, Num 5, pp 1967-1974, issn 0022-538XArticle

The Epstein-Barr virus: host balance in acute infectious mononucleosis patients receiving acyclovir anti-viral therapyYAO, Q. Y; OGAN, P; ROWE, M et al.International journal of cancer. 1989, Vol 43, Num 1, pp 61-66, issn 0020-7136Article

Epstein-Barr virus in Hodgkin's diseaseCHAPMAN, A. L. N; RICKINSON, A. B.Annals of oncology. 1998, Vol 9, pp 5-16, issn 0923-7534, SUP5Conference Paper